Middle East And Asia Pacific Cell And Gene Therapy Market is Estimated To Witness High Growth Owing To Increasing Disease Burden

 
Middle East and Asia Pacific Cell And Gene Therapy Market

Market Overview:

The Middle East and Asia Pacific Cell And Gene Therapy Market Share comprises treatments that utilize cellular therapies and genetic modifications to repair damaged tissues and cells. These therapies deliver new cells, tissues or genes into patients to combat medical conditions. Cell therapies are derived from either autologous or allogenic sources while gene therapies involve the correction of genetic defects. The demand for these advanced treatment options is driven by their ability to potentially cure chronic diseases.

Market key trends:
The increasing prevalence of cancer and other life-threatening illnesses is a key factor augmenting the Middle East And Asia Pacific cell and gene therapy market growth. As per the World Health Organization, cancer cases in the Asia Pacific region are estimated to increase by 80% by 2030. Moreover, chronic diseases such as cardiovascular disorders are also on the rise in the Middle East region due to changing lifestyles. Cell and gene therapies present innovative solutions that can potentially provide long-lasting therapeutic effects by addressing the underlying causes at the cellular and genetic level. Increased healthcare investments by governments to make these novel treatment avenues more accessible to patients is fueling the market expansion.

Porter’s Analysis
Threat of new entrants: the Middle East and Asia Pacific cell and gene therapy market poses moderate threat of new entrants due to high level of investment required for R&D, manufacturing facilities and complexity of therapy development.
Bargaining power of buyers: buyers hold moderate bargaining power due to availability of limited product options and high treatment costs in this specialized therapy area.
Bargaining power of suppliers: suppliers have low to moderate bargaining power due to presence of a large number of raw material and service providers catering to this market
Threat of new substitutes: threat is low due to lack of effective substitutes for cell and gene therapies which are targeted therapies addressing specific medical conditions.
Competitive rivalry: the competition is high among existing players to develop new therapies and gain maximum market share.

SWOT Analysis
Strength: Availability of advanced healthcare infrastructure and high disposable incomes in the Asia Pacific region. Growing awareness about cell and gene therapies.
Weakness: High therapy costs making it unaffordable for majority. Stringent regulatory guidelines delaying product approvals.
Opportunity: Increasing prevalence of cancer, cardiovascular diseases and other genetic disorders driving demand. Favorable government initiatives supporting research.
Threats: Risk of therapy failure and side effects. Dependency on limited product pipelines of few large players.

Key Takeaways
The global Middle East And Asia Pacific Cell And Gene Therapy Market is expected to witness high growth, exhibiting CAGR of 17% over the forecast period, due to increasing prevalence of chronic diseases. The rising awareness about advanced therapies and favorable regulatory reforms supporting clinical trials will further support the market growth during the forecast period.

Regional analysis: Asia Pacific region dominates the market and is fastest growing region owing to presence of emerging economies like China and India experiencing high economic growth. High unmet medical needs and improving healthcare infrastructure in the region provide immense opportunities for cell and gene therapy providers.

Key players operating in the Middle East And Asia Pacific cell and gene therapy market include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Bluebird Bio, Inc. (Celgene Corporation), Gene biotherapeutics, Sibiono GeneTech Co. Ltd., Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Biogen INC., Organogenesis, Inc., JCR Pharmaceuticals Co. Ltd, uniQure N.V., WuxiAppTec, Lonza, and Immuneel Therapeutics Pvt Ltd.

 

Read More:

https://www.dailyprbulletin.com/the-middle-east-and-asia-pacific-cell-and-gene-therapy-market/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more